'''AstraZeneca plc''' ({{IPAc-en|ˌ|æ|s|t|r|ə|ˈ|z|ɛ|n|ə|k|ə}}) is a [[United Kingdom|British]]–[[Swedish]] [[Multinational corporation|multinational]] [[pharmaceutical]] and [[biopharmaceutical]] company with its headquarters in [[Cambridge]], England. < ref > {{cite web |title=Registered office and corporate headquarters |url=https://www.astrazeneca.com/investor-relations/annual-reports/annual-report-2016/contact-information.html |access-date=27 February 2020 |publisher=AstraZeneca}} < /ref >  It is registered in London, United Kingdom. AstraZeneca Plc was formed in 1999 by merging the Swedish Astra AB and the British Zeneca Ltd. Drugs produced by the company are sold in more than 100 countries. More than 57 thousand people work for the company. AstraZeneca's [[Factory|factories]] are in 20 countries. Sales in 2012 amounted to almost 28 billion dollars. 
 
 Pascal Soriot was the best-paid [[FTSE-100|FTSE]] [[Chief executive officer|chief executive]] in 2022, with a total package of £15.3 million.   
 
 The [[Share (finance)|share]] price has risen about 80% in the past five years. < ref > {{Cite news|last=Pickard|first=Jim|last2=Parker|first2=George|last3=O’Dwyer|first3=Michael|date=2023-08-21|title=FTSE 100 bosses given average 16% pay rises|work=Financial Times|url=https://www.ft.com/content/3a55f34e-466b-4649-8f75-95188fe7ce80|access-date=2023-08-22}} < /ref > 
 
 AstraZeneca creates treatments for [[cancer]], [[circulatory system|cardiovascular]], [[human gastrointestinal tract|gastrointestinal]], infection, [[neuroscience]], [[respiratory system|respiratory]] and [[inflammation]]. < ref name= " AboutUs " > {{cite web |title=AstraZeneca - About Us |url=http://www.astrazeneca.com/about-us/ |website=astrazeneca.com}} < /ref > 
 
 ==References== 
 {{reflist}} 
 
 
 {{Multistub|UK|europe}} 
 
 [[Category:Companies based in London]] 
 [[Category:Companies of Sweden]] 
 [[Category:Organisations based in Cambridge]] 
 [[Category:Pharmaceutical companies of Europe]]